ENLITIC, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.17 AUD | 0.00% |
|
-34.62% | -80.23% |
| 06-17 | Enlitic Enters New Partnerships with Esaote, Clairvo, DataFirst | MT |
| 06-03 | Enlitic Launches New Version of Medical Technology Software | MT |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 50.53 | 9.774 | - | - |
| Enterprise Value (EV) 1 | 39.44 | 8.774 | 8.074 | 9.774 |
| P/E ratio | -3.25 x | -1.13 x | - | - |
| Yield | - | - | - | - |
| Capitalization / Revenue | 107 x | 1.5 x | 0.55 x | - |
| EV / Revenue | 83.9 x | 1.35 x | 0.45 x | - |
| EV / EBITDA | -2.61 x | -0.9 x | 6.73 x | 0.81 x |
| EV / FCF | -2.65 x | -0.9 x | 7.34 x | - |
| FCF Yield | -37.7% | -112% | 13.6% | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 86,279 | 86,368 | - | - |
| Reference price 2 | 0.5857 | 0.1132 | 0.1132 | 0.1132 |
| Announcement Date | 24-02-28 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | 0.9032 | 0.4703 | 6.5 | 17.9 | - |
| EBITDA 1 | - | -15.1 | -9.7 | 1.2 | 12.1 |
| EBIT 1 | - | -15.5 | -9.9 | 1 | - |
| Operating Margin | - | -3,294.86% | -152.31% | 5.59% | - |
| Earnings before Tax (EBT) 1 | - | -15.55 | -9.8 | 1.1 | - |
| Net income 1 | -25.04 | -15.55 | -9.8 | 1.1 | - |
| Net margin | -2,772.39% | -3,306.78% | -150.77% | 6.15% | - |
| EPS 2 | - | -0.1802 | -0.1000 | - | - |
| Free Cash Flow 1 | - | -14.88 | -9.8 | 1.1 | - |
| FCF margin | - | -3,165.02% | -150.77% | 6.15% | - |
| FCF Conversion (EBITDA) | - | - | - | 91.67% | - |
| FCF Conversion (Net income) | - | - | - | 100% | - |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 23-12-18 | 24-02-28 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | 11.1 | 1 | 1.7 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | -14.9 | -9.8 | 1.1 | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | -212% | -365% | 24.6% | - |
| Assets 1 | - | 7.337 | 2.682 | 4.472 | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share 2 | - | -0.1700 | -0.1100 | 0.0200 | - |
| Capex 1 | - | 0 | 0.3 | 0.3 | 0.3 |
| Capex / Sales | - | 0.97% | 4.62% | 1.68% | - |
| Announcement Date | 23-12-18 | 24-02-28 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -80.23% | 9.79M | |
| +3.23% | 3.48B | |
| +2.19% | 3.15B | |
| -31.67% | 1.66B | |
| -30.99% | 568M | |
| -14.50% | 322M | |
| -37.86% | 268M | |
| -21.43% | 185M | |
| -12.69% | 172M | |
| +6.28% | 142M |
- Stock Market
- Equities
- ENL Stock
- Financials Enlitic, Inc.
